In addition, combined blockade of PD-L1 checkpoint and expression of YTHDF1, FTO, and METTL3/14 was able to improve the significant effect in the treatment of CRC and leukemia [161, 237, 238]. This evidence concerns the gene METTL3 and colorectal carcinoma.